Dipeptidyl peptidase-4 (DPP-4) inhibitors were first investigated in 2002 for the management of hyperglycemia in patients with type 2 diabetes
132, n o 2, 204210 (ISSN 0022-3166 et 1541-6100, DOI 10.1093/jn/132.2.204, lire en ligne, consult le
This drug should be made available at a reasonable price for everybody whos got weight loss problems, she said
doi: 10.1038/s41467-021-27414-1 21 UrsiniFMaiorinoMValenteMFerriLGregolinC
However, more than four decades later, in light of significant epidemiological changes driven by shifts in lifestyle and new dietary habits worldwide, questions began to emerge regarding the adequacy of this terminology
The activation of the serine biosynthetic pathway may represent a significant contribution to the pro-tumorigenic activity of NRF2